SAFE Investment Opportunity
Early-stage access to The Elkan Group, LLC through a post-money, valuation-cap-only SAFE for verified accredited investors.
SAFE Investment Opportunity
The Elkan Group, LLC, the proposed energy operator, is seeking $600,000 through post-money, valuation-cap-only SAFEs offered to accredited investors. The offering has a $30 million post-money valuation cap, no discount, and a $7,500 minimum investment.
The funding is intended to support Cruxeon Energy+’s technical validation and engineering development. Investors receive contractual rights under the SAFE, rather than an immediate equity ownership interest.
The Elkan Group, LLC is the issuer. Cruxeon, LLC separately owns the Cruxeon Energy+ brand and its energy technology and intellectual property. The investment is not a direct purchase of ownership in an individual generator or a separately issued Cruxeon Energy+ investment vehicle. Investor rights and any future equity issuance are governed by the definitive offering documents.
About the SAFE Offering
A SAFE—Simple Agreement for Future Equity—is an early-stage financing instrument that gives an investor contractual rights to future non-voting interests in Elkan and specified event proceeds upon events defined in the agreement.
- The post-money valuation cap is $30 million.
- There is no discount.
- The SAFE does not accrue interest.
- There is no maturity date or scheduled repayment.
- No equity ownership interest is issued at the time of investment.
- The SAFE automatically converts upon an Equity Financing as defined in the agreement.
- A liquidity event or dissolution before conversion may result in a payment, subject to the agreement’s calculations, payment priorities, and available proceeds.
The valuation cap establishes a conversion calculation; it is not a guarantee of the company’s current value, future value, or investment return. Conversion is not guaranteed. If no triggering event occurs, the SAFE may remain outstanding indefinitely.
Why Cruxeon Energy+ Is Using a SAFE
Cruxeon Energy+ is developing a proprietary energy generation system. Its immediate priority is technical validation and engineering development. Commercial output, operating costs, reliability, and deployment readiness have not yet been independently established.
The SAFE allows The Elkan Group, LLC to raise development capital without completing a priced equity financing today. It establishes contractual terms for future conversion while supporting work needed to evaluate technical performance and commercial feasibility.
The current funding target is $600,000. Any additional financing will require separate company approval and consideration of capital requirements, investor obligations, and ownership effects.
Use of Proceeds
The $600,000 funding target is intended to support technical validation and engineering development, including:
- Prototype and system-component development.
- Instrumented testing and measurement of all external energy inputs and usable energy outputs.
- Engineering refinement and evaluation of operating stability and repeatability.
- Independent technical assessment.
- Evaluation of safety and applicable certification requirements.
- Legal, operational, and demonstration-project planning associated with the development program.
Detailed allocations and milestones are provided in the investor materials. Actual spending and timing may change as testing identifies additional requirements. Commercial deployment and larger pilot projects may require additional financing.
Investment Structure
At the initial closing of an Equity Financing as defined in the SAFE, the agreement automatically converts according to its financing-price and valuation-cap calculations. If a liquidity event occurs before conversion, the investor is entitled to proceeds calculated under the SAFE, subject to its payment priorities. Additional rights apply only if expressly granted in an executed agreement or side letter. The definitive offering documents govern all investment terms.
Eligibility
This offering is available only to accredited investors, as defined under applicable U.S. securities laws, and only where the offering is legally permitted. Before accepting an investment, The Elkan Group, LLC will take reasonable steps to verify the purchaser’s accredited-investor status as required for a Rule 506(c) offering.
How to Learn More
- Submit the investor inquiry form.
- Complete the requested eligibility review.
- Review the definitive offering documents, development plan, financial information, and risk disclosures.
- Complete accredited-investor verification and the investment documentation before any investment is accepted.
An inquiry does not create an investment commitment. Investors should obtain their own legal, financial, and tax advice. We do not accept funds directly through this website.
Important Disclosure
The Elkan Group, LLC is conducting an unregistered securities offering intended to rely on Rule 506(c) of Regulation D. Purchases are limited to verified accredited investors.
The SAFE and any securities issued upon conversion are restricted and may be difficult or impossible to resell. There is no guarantee of conversion, liquidity, successful technical validation, commercialization, or investment return. Investors may lose their entire investment.
This page summarizes the opportunity and does not contain all material terms or risks. Investors must review the definitive offering documents before investing. Those documents govern the investment. We do not accept funds directly through this website.
SAFE Investment FAQs
What exactly am I investing in?
You are purchasing a SAFE issued by The Elkan Group, LLC, the proposed energy operator; Cruxeon, LLC separately owns the energy technology, IP, and Cruxeon Energy+ brand. The SAFE provides contractual rights to future non-voting interests in Elkan and specified event proceeds upon events defined in the agreement. You are not receiving equity ownership today or purchasing an interest in an individual generator.
Is this a debt instrument?
The SAFE is not a conventional loan. It does not accrue interest, have a maturity date, or provide scheduled repayment. It does provide specified payment rights upon a liquidity event or dissolution, subject to its terms, payment priorities, and available proceeds.
When do I receive equity?
Any conversion upon an Equity Financing is governed by the definitive SAFE agreement, including its applicable triggers and conditions. A liquidity event before conversion is handled under the SAFE’s proceeds provisions and does not necessarily result in equity being issued. The definitive agreement controls.
What happens if there is no future financing?
If no conversion, liquidity, or dissolution event occurs, the SAFE may remain outstanding indefinitely. You cannot demand repayment simply because time has passed. There is no guaranteed conversion date or investment return.
Is there a valuation cap or discount?
Yes. The offering has a $30 million post-money valuation cap and no discount. The cap is used in the SAFE’s conversion calculations; it is not a guarantee of the company’s current value.
Is there a minimum investment amount?
The current minimum investment is $7,500. Investment acceptance is subject to accredited-investor verification, company acceptance, and execution of the required documents.
Do SAFE holders have voting rights or control?
The SAFE does not grant voting rights or a board seat before conversion. After conversion, voting and other rights are determined by the non-voting interests issued and the applicable governing and financing documents.
How is this different from a convertible note?
A convertible note generally accrues interest and has a maturity date. This SAFE has neither. It provides future equity rights and specified liquidity and dissolution provisions.
How will my ownership percentage be determined?
The number of non-voting interests issued at conversion is determined by the SAFE’s financing-price and valuation-cap calculations and the company’s capitalization. Your investment does not establish a fixed ownership percentage today.
How will the funds be used?
The current $600,000 target supports prototype development, testing, engineering refinement, independent technical assessment, and related development readiness. Additional financing may be required for subsequent development or commercial deployment.
Is this offering registered with the SEC?
No. The offering is intended to rely on Rule 506(c) of Regulation D, an exemption from securities registration. Purchasers must be accredited investors, and their status must be verified.
Can I resell or transfer my SAFE?
Transfers are restricted by securities laws and the agreement. The SAFE generally requires written consent for transfers, subject to specified exceptions. There is no assurance that a resale market will exist.
What are the risks?
Risks include unsuccessful technical validation, development delays, additional funding needs, commercial or regulatory obstacles, dilution, and lack of liquidity. Conversion, commercialization, and investment returns are not guaranteed. You could lose your entire investment.
How do I proceed if I am interested?
Submit an investor inquiry through the website. You will receive instructions for eligibility review, access to offering materials, accredited-investor verification, and investment documentation. No funds are accepted directly through this website.
Investment enquiry options
Speak directly with our team
Introduce yourself and ask questions without submitting financial documents.
Make an enquiryView the Elkan SAFE raise
Review the published fundraising profile and related investment information on EquityNet.
View on EquityNet ↗